BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19049950)

  • 21. Metastatic carcinoma of the scalp.
    Miller JL
    Arch Dermatol; 1970 Aug; 102(2):231. PubMed ID: 4317165
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment information and the radiotherapy patient.
    Andrew C
    Radiogr Today; 1991 Sep; 57(652):25-9. PubMed ID: 1755956
    [No Abstract]   [Full Text] [Related]  

  • 23. Erosive pustular dermatosis and osteoradionecrosis: complications of radiotherapy.
    Skellett AM; Levell NJ
    Clin Exp Dermatol; 2011 Jan; 36(1):98-9. PubMed ID: 20608943
    [No Abstract]   [Full Text] [Related]  

  • 24. Helical tomotherapy in oncodermatology: case report of circumferential cutaneous lymphoma treated by this optimized radiotherapy.
    Servy A; Kramkimel N; Franck N; Park S; Kirova YM
    Cancer Radiother; 2014 Mar; 18(2):136-8. PubMed ID: 24418001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy for head and neck cancer--is the "next level" down?
    Mendenhall WM; Mancuso AA
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):645-6. PubMed ID: 19215816
    [No Abstract]   [Full Text] [Related]  

  • 27. [Radiotherapy-induced scalp angiosarcoma].
    Coronel-Pérez IM; Cantalejo-Rodríguez C; Herrera-Saval A; Mesa-Sáenz C; Ríos-Martín JJ; Camacho-Martínez F
    Actas Dermosifiliogr; 2007 Jun; 98(5):373-4. PubMed ID: 17555686
    [No Abstract]   [Full Text] [Related]  

  • 28. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The optimization of intensity modulated radiotherapy in cases where the planning target volume extends into the build-up region.
    Nguyen TB; Hoole AC; Burnet NG; Thomas SJ
    Phys Med Biol; 2009 Apr; 54(8):2511-25. PubMed ID: 19336846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
    Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scalp angiosarcoma with pulmonary metastases.
    Haris M; Koulaouzidis A; Chattington P
    Intern Med J; 2007 Dec; 37(12):833-4. PubMed ID: 18028087
    [No Abstract]   [Full Text] [Related]  

  • 32. [Epithelial neoplasms of the scalp (late results of radiotherapy)].
    Moretti S; Babini L; Gavelli GP
    Radiobiol Radioter Fis Med; 1965; 20(6):450-61. PubMed ID: 5860894
    [No Abstract]   [Full Text] [Related]  

  • 33. Inoperable scalp cutaneous angiosarcoma: Complete response after definitive external beam radiation therapy - brachytherapy association.
    Le Roy C; Le Péchoux C; Alapetite C; Bahleda R; Ngo C; Honoré C; Faron M; Le Cesne A; Mir O; Haie-Meder C; Chargari C; Levy A
    Oral Oncol; 2022 Feb; 125():105715. PubMed ID: 35030408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful radiotherapy of facial angiosarcoma.
    Gkalpakiotis S; Arenberger P; Vohradnikova O; Arenbergerova M
    Int J Dermatol; 2008 Nov; 47(11):1190-2. PubMed ID: 18986458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early clinical experience and outcome of helical tomotherapy for multiple metastatic lesions.
    Lee IJ; Seong J; Lee CG; Kim YB; Keum KC; Suh CO; Kim GE; Cho J
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1517-24. PubMed ID: 19084348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collision tumour of squamous cell carcinoma and invasive malignant melanoma of scalp - a case report.
    Mopuri N; Laitung JK; Cardozo C
    J Plast Reconstr Aesthet Surg; 2009 May; 62(5):e104-5. PubMed ID: 19064339
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
    Zuur CL; Simis YJ; Lamers EA; Hart AA; Dreschler WA; Balm AJ; Rasch CR
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):490-6. PubMed ID: 19135315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck.
    Mendenhall WM; Amdur RJ; Hinerman RW; Cognetta AB; Mendenhall NP
    Laryngoscope; 2009 Oct; 119(10):1994-9. PubMed ID: 19688856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indications and outcomes of radiation therapy for skin cancer of the head and neck.
    Wang Y; Wells W; Waldron J
    Clin Plast Surg; 2009 Jul; 36(3):335-44. PubMed ID: 19505606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thorium X and skin cancer: still a problem in the 21st century.
    Rajaratnam R; Balasubramaniam P; Marsden JR
    Clin Exp Dermatol; 2007 Jan; 32(1):125-6. PubMed ID: 17034422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.